Table 2 Prevalence and distribution of premalignant cervical lesions by Pap smear results among women attending cervical cancer screening at Mbarara Regional Referral Hospital, March–May 2022
Pap smear result | Overall (N = 413) | HIV positive (n = 203) | HIV negative (n = 210) | p-value | |||
|---|---|---|---|---|---|---|---|
N | (%) | n | (%) | n | (%) | ||
Premalignant cervical lesions | 72 | (17) | 47 | (23) | 25 | (12) | 0.003* |
HSIL | 8 | (2) | 7 | (15) | 1 | (4) | 0.001* |
LSIL | 55 | (13) | 35 | (74) | 20 | (80) | 0.001* |
ASCUS | 9 | (2) | 5 | (11) | 4 | (16) | 0.001* |